PortViewPortView
Glaukos logo

Glaukos (GKOS) Stock Analysis

NYSEHealthcareMedical - Devices

$179.02+1.31%
1-year price historyRange $74.67 – $189.55
52-week range$179.02
$73.16$191.62

What Glaukos does

Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.

Key metrics

Market cap
$10.56B
P/E (TTM)
-208.16
EPS (TTM)
$-0.86
Beta
0.76
Dividend yield
0.00%
Revenue / share
$10.49
50-day avg
$164.22
200-day avg
$128.00
52-week high
$191.62
52-week low
$73.16
CEO
Thomas William Burns

ETFs linked to GKOS

Broad-market and Healthcare sector ETFs an investor holding Glaukos is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GKOS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GKOS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Glaukos?
Glaukos trades under the ticker GKOS on NYSE.
Which exchange is GKOS listed on?
GKOS is listed on NYSE.
What sector does Glaukos operate in?
Glaukos is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze GKOS in a portfolio?
PortView shows GKOS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.